Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CILOSTAZOL
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
- BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
- EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)
- Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
- A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.
- The Effects of Cilostazol Dexborneol on Microcirculation Dysfunction and Thrombo-inflammation in Patients With Acute Ischemic Stroke After Reperfusion Therapy
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache
- Cilostazol and Low Dose of Methotrexate in Rheumatoid Arthritis
- BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
- Efficacy of Cilostazol in Prevention of Peripheral Neuropathy
- Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
- Cilostazol for HFpEF
- Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease
- The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis
- Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease
- Retina is a Marker for Cerebrovascular Heath
- The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
- Cilostazol and Endothelial Progenitor Cell
- Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.
- Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
- Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial
- VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.
- Trimetazidine as an Adjunct to Enhance Clopidogrel Response.
- Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
- Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea
- Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
- LACunar Intervention (LACI-2) Trial-2
- The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache
- Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
- Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
- Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
- Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
- Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
- Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
- Ramipril Treatment of Claudication
- Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
- Cilostazol Following Peripheral Endovascular Procedures
- Pharmacodynamic Study of Cilostazol in Healthy Volunteers
- Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
- A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)
- The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
- PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
- Lacunar Intervention Trial 1 (LACI-1)
- Cilostazol-Simvastatin Drug Interaction Study
- Cilostazol After Lower Extremity Arterial Revascularization Trial
- Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia
- Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
- Induction of Migraine Aura With Cilostazol
- Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
- Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
- Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)
- To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatmen
- Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
- A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
- Cilostazol Stroke Prevention Study for Antiplatelet Combination
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
- Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
- Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
- Cilostazol and Its Effects on Resumption of Meiosis in the Human Ovary
- Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)
- Pharmacodynamic Drug Interaction Between Cilostazol and Statins
- The Headache Inducing Effects of Cilostazol on Migraine Patients
- Pletaal SR Post Marketing Observational Study
- Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
- A Multicenter, Therapeutic Used Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease
- The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers
- Safety and Pharmacokinetic Comparison of Cilostazol SR and IR Formulations in Healthy Korean Volunteers
- Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
- Cilostazol Augmentation Study in Dementia
- Effect of Cilostazol on the Pharmacokinetics of Simvastatin
- A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus
- Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.
- ACCEL-LOADING-ACS Study
- Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
- Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
- Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients
- Carotid Artery Stenting With Cilostazol Addition for Restenosis
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
- Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation
- The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
- Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease
- Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
- Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
- Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
- Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease
- Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)
- PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
- Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
- Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
- Sufficient Treatment of Peripheral Intervention by Cilostazol
- Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism
- Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
- To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
- To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
- Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
- Cilostazol 50 mg Tablets Under Fasting Conditions
- Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
- Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
- Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
- Evaluation of Cilostazol in Combination With L-Carnitine
- The Efficacy of CILostazol ON Ischemic Complications After DES Implantation
- A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions
- Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
- Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler
- Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo
- Fasted Bioavailability Study of Cilostazol Tablets, 50mg
- Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
- Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg
- The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol
- Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions
- Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions
- Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
- Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
- Safety and Pharmacokinetics of Probucol and Cilostazol
- Overcome Biochemical Aspirin Resistance Through Cilostazol Combination
- Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
- Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
- Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation
- Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
- Mixed Antagonist of Serotonin for Claudication Optimal Therapy
- L-Arginine in the Treatment of Peripheral Arterial Disease
- The Use of Cilostazol in Patients With Diabetic Nephropathy
- Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
- Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
- Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
- Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
- Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
- Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
- Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
Clinical trials list
click for details